Cheng F - Search Results

1

[Clinical and genetics characteristics of patients with monosomal karyotype acute myeloid leukemia patients].

Cheng F, Ma X, Pan J, Wu Y, Zhang J, Xue Y, Wang Q, Yao H, Wen L, Shen Y, Chen S. Cheng F, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Aug;31(4):508-10. doi: 10.3760/cma.j.issn.1003-9406.2014.04.022. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014. PMID: 25119923 Chinese.

2

Preclinical evaluation of WYE-687, a mTOR kinase inhibitor, as a potential anti-acute myeloid leukemia agent.

Cheng F, Wang L, Shen Y, Xia J, Chen H, Jiang Y, Lu M. Cheng F, et al. Biochem Biophys Res Commun. 2016 Feb 5;470(2):324-330. doi: 10.1016/j.bbrc.2016.01.054. Epub 2016 Jan 11. Biochem Biophys Res Commun. 2016. PMID: 26792718

3

The prognostic value of the controlling nutritional status score in patients with myelodysplastic syndrome.

Qian J, Wang J, Cheng F, Guo HF, Xia J, Zhou X. Qian J, et al. Among authors: cheng f. Support Care Cancer. 2022 Nov;30(11):8997-9002. doi: 10.1007/s00520-022-07313-x. Epub 2022 Aug 8. Support Care Cancer. 2022. PMID: 35939237

4

Short-course bortezomib-based retreatment for patients with multiple myeloma who had received bortezomib-thalidomide-dexamethasone (VTD) as an initial therapy: A single-center case series.

Mao J, Cheng F, Chen H, Wang J, Zhou X, Jiang Y, Zhu Y, Guo H. Mao J, et al. Among authors: cheng f. Exp Ther Med. 2014 Apr;7(4):977-981. doi: 10.3892/etm.2014.1496. Epub 2014 Jan 23. Exp Ther Med. 2014. PMID: 24669261 Free PMC article.

5

Evaluation of pretreatment red cell distribution width in patients with multiple myeloma.

Wang J, Xie X, Cheng F, Zhou X, Xia J, Qian X, Wang L, Guo H. Wang J, et al. Among authors: cheng f. Cancer Biomark. 2017 Sep 7;20(3):267-272. doi: 10.3233/CBM-170032. Cancer Biomark. 2017. PMID: 28826172

6

Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience.

Zhou X, Xia J, Mao J, Cheng F, Qian X, Guo H. Zhou X, et al. Among authors: cheng f. Hematology. 2016 Jun;21(5):280-6. doi: 10.1080/10245332.2015.1122259. Epub 2016 Mar 1. Hematology. 2016. PMID: 26900623 Free article. Clinical Trial.

7

Inhibition of miR-448-3p Attenuates Cerebral Ischemic Injury by Upregulating Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2).

Xu M, Xiang D, Wang W, Chen L, Lu W, Cheng F. Xu M, et al. Among authors: cheng f. Neuropsychiatr Dis Treat. 2021 Oct 19;17:3147-3158. doi: 10.2147/NDT.S310495. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34703235 Free PMC article.

8

External Ventricular Drains versus Intraparenchymal Intracranial Pressure Monitors in Traumatic Brain Injury: A Prospective Observational Study.

Liu H, Wang W, Cheng F, Yuan Q, Yang J, Hu J, Ren G. Liu H, et al. Among authors: cheng f. World Neurosurg. 2015 May;83(5):794-800. doi: 10.1016/j.wneu.2014.12.040. Epub 2014 Dec 23. World Neurosurg. 2015. PMID: 25541084

9

A Retrospective Study of Intracranial Pressure in Head-Injured Patients Undergoing Decompressive Craniectomy: A Comparison of Hypertonic Saline and Mannitol.

Cheng F, Xu M, Liu H, Wang W, Wang Z. Cheng F, et al. Front Neurol. 2018 Jul 31;9:631. doi: 10.3389/fneur.2018.00631. eCollection 2018. Front Neurol. 2018. PMID: 30131757 Free PMC article.

10

AntagomiR-613 protects neuronal cells from oxygen glucose deprivation/re-oxygenation via increasing SphK2 expression.

Di G, Wang Z, Wang W, Cheng F, Liu H. Di G, et al. Among authors: cheng f. Biochem Biophys Res Commun. 2017 Nov 4;493(1):188-194. doi: 10.1016/j.bbrc.2017.09.049. Epub 2017 Sep 12. Biochem Biophys Res Commun. 2017. PMID: 28916166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,781 results

Search Page

Filters